Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elanco Animal Health Incorporated Common Stock vs Lithium Americas Corp — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.69 (market cap $11.26B), while Lithium Americas Corp trades at $2.39 (market cap $850.38M). The key difference: Elanco Animal Health Incorporated Common Stock is far larger — about 13.2× Lithium Americas Corp's market cap, and Elanco Animal Health Incorporated Common Stock is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Lithium Americas Corp for 27 Days on average.
| ELAN | LAC | |
|---|---|---|
Market Cap | $11.26B | $850.38M |
Volume | 4,570,386 | 8,804,637 |
Sector | Health | Basic Materials |
52-Week High | $26.84 | $10.05 |
52-Week Low | $19.76 | $2.36 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $14.65B | $1.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lithium Americas (LAC) trades at $2.41, down 5.12% in the last session, reflecting ongoing market pressure despite recent earnings beats. The company shows negative profitability metrics with a -9.56% ROE and -$122.09M net income for 2025, though it maintains strong financing activity with $1.14B in cash flow from financing. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators suggest potential oversold conditions. Recent news highlights construction progress at Thacker Pass as a key development catalyst.
The investment outlook remains speculative with significant execution risk at Thacker Pass offset by analyst optimism (46.67% buy rating) and a $4.00 consensus price target representing 66% upside. Key risks include lithium price volatility, project execution challenges, and sustained negative cash flow from operations. The stock's current valuation at 0.6x book value may attract value investors betting on successful project commercialization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elanco Animal Health Incorporated Common Stock
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
